D2M Biotherapeutics

Grand Cayman, Cayman Islands

D2M Biotherapeutics focuses on the development of novel immunotherapeutics.

Apr 2023

Series A

Biotechnology Health Care Therapeutics

Top Investors

RiverHead Capital Delian Capital Longpan Investment Apricot Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about D2M Biotherapeutics

Who are D2M Biotherapeutics's investors?

D2M Biotherapeutics's investors include RiverHead Capital, Delian Capital, Longpan Investment, Apricot Capital.

Where is D2M Biotherapeutics headquartered?

D2M Biotherapeutics is headquartered in Grand Cayman, Cayman Islands.

What does D2M Biotherapeutics do?

D2M Biotherapeutics focuses on the development of novel immunotherapeutics.

What stage is D2M Biotherapeutics at?

D2M Biotherapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 3, 2023.

MLA

"D2M Biotherapeutics — Funding & Investors." VCBacked, April 3, 2023, https://www.vcbacked.co/company/d2m-biotherapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). D2M Biotherapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/d2m-biotherapeutics

Wikipedia (cite web)

{{cite web |title=D2M Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/d2m-biotherapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 3, 2023.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K